NCT07173179View on ClinicalTrials.gov

Papillary Epinephrine Injection Combined With Rectal Indomethacin

PHASE4CompletedINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

July 1, 2022

Primary Completion Date

February 1, 2023

Study Completion Date

April 1, 2023

Conditions
Post-ERCP Acute Pancreatitis
Interventions
DRUG

Papillary epinephrine injection combined with rectal indomethacin

All patients in this group receive preprocedural 100mg indomethacin spp and post-procedure 4 ml of undiluted epinephrine injected around the duodenal papilla on four quadrants, over a period of 60 seconds using a sclerotherapy needle

DRUG

Rectal indomethacin alone

All patients in this group receive preprocedural 100mg indomethacin spp

Trial Locations (1)

81620

Duzce University School of Medicine, Düzce

All Listed Sponsors
lead

Duzce University

OTHER